(Q34597128)

3 August 2017

Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study (English)

1 reference

3 August 2017

0 references

1 reference

1 reference

Stephen D. Silberstein

series ordinal

4

object named as

Stephen Silberstein

1 reference

3 August 2017

Michael M Tuchman

1

1 reference

3 August 2017

Angela Hee

series ordinal

2

1 reference

3 August 2017

Ugochi Emeribe

series ordinal

3

1 reference

3 August 2017

1 January 2008

1 reference

3 August 2017

1 reference

3 August 2017

22

1 reference

3 August 2017

10

1 reference

3 August 2017

877-886

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200822100-00007

3 August 2017

0 references

cites work

Prevalence of migraine on each day of the natural menstrual cycle

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822100-00007

A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822100-00007

A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822100-00007

Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822100-00007

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

21 January 2018

1 reference

12 December 2020

Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine

1 reference

12 December 2020

The clinical pharmacokinetics of zolmitriptan.

1 reference

12 December 2020

Naratriptan in the short-term prophylaxis of pure menstrual migraine.

1 reference

12 December 2020

The role of estradiol withdrawal in the etiology of menstrual migraine

1 reference

12 December 2020

The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group

1 reference

12 December 2020

Zolmitriptan provides consistent migraine relief when used in the long-term

1 reference

12 December 2020

Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study

1 reference

12 December 2020

Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.

1 reference

12 December 2020

Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres.

1 reference

12 December 2020

Menstrual migraines: etiology, treatment, and relationship to premenstrual syndrome.

1 reference

12 December 2020

The influence of estrogen on migraine: a systematic review

1 reference

12 December 2020

Menstrual Migraine in A Representative Dutch Population Sample: Prevalence, Disability and Treatment

1 reference

12 December 2020

Menstrual cycle and headache in a population sample of migraineurs

1 reference

12 December 2020

Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group

1 reference

12 December 2020

The use of triptans in the management of menstrual migraine

1 reference

12 December 2020

Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.

1 reference

12 December 2020

Is menstrually associated migraine difficult to treat?

1 reference

12 December 2020

Migraine and menstruation: a pilot study

1 reference

12 December 2020

Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies

1 reference

12 December 2020

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society

1 reference

12 December 2020

Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine

1 reference

12 December 2020

10.2165/00023210-200822100-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference